People excluded from mainstream society in high-income countries have a tenfold increased risk of early death, according to research published in The Lancet.
Machine learning could improve our ability to determine whether a new drug works in the brain, potentially enabling researchers to detect drug effects that would be missed entirely by conventional tests, according to a study published today in Brain.
Doctors at UCLH are trialling a biological combination treatment for patients with the disabling condition lupus.
Researchers have been awarded over £600,000 to investigate the emerging link between dementia risk and hearing loss.
Physical activity is associated with a reduced risk of Alzheimer's disease, according to a study published in Alzheimer’s & Dementia.
Imagine a world in which you can think but cannot speak. For many stroke survivors this nightmare is a reality; this Sunday their story is told in an intensely moving and personal film about language and its loss.
Doctors at UCLH are investigating whether a blood‐clot promoting drug could help stop bleeding within the brain in stroke patients.
The BRC spoke to Professor Rob Howard, Mental Health Theme Lead and Professor of Old Age Psychiatry at UCL, on World Mental Health Day about better treatments for people with dementia and psychosis.
The first trial of an experimental treatment for liver cancer, using X-ray imageable microscopic beads loaded with a targeted anti-cancer drug placed directly in the liver, has begun.
The National Institute for Health Research Clinical Research Network Oral and Dental Health Specialty has announced a new opportunity to identify future priorities relating to oral and dental health research.
UCL Business and AGA Nanotech Ltd have concluded a licensing agreement for use of TIPS microparticle technology in directing the controlled delivery of antimicrobial agents in the healthcare setting.
UCL spinout company Autolus has secured £59 million of investment to develop T-cell therapies that could revolutionise the way cancer is treated.
An investigational treatment that mimics a key clotting enzyme is effective, safe, and may one day eliminate the need for blood products for people with a life-threatening blood disease, according to a study published today.
The BRC spoke with Dr Jonathan Schott, consultant neurologist and dementia researcher from the UCL Institute of Neurology about detection, trends and the future for Alzheimer’s disease during World Alzheimer’s Month.
Premature births breakthrough: researchers discover potential way to heal ruptures in membrane that surrounds a fetus in the womb
Researchers have found a potential way of preventing premature births by healing unwanted ruptures in the delicate membrane that surrounds a fetus in the womb.